Skip to main content
Premium Trial:

Request an Annual Quote

Ariadne Licenses PathwayStudio to Belgian Pharma UCB

NEW YORK, Jan. 11 (GenomeWeb News) - Ariadne Genomics has licensed its PathwayStudio software to UCB, a Belgian biopharmaceutical company, Ariadne said today.

 

UCB will use Pathway Studio for its research on nervous system disorders, allergy and respiratory diseases, immune and inflammatory disorders, and oncology, Ariadne said.

 

The PathwayStudio package comes with Ariadne's ResNet database of 500,000 functional relationships and MedScan modules for automatic extraction of information from scientific literature, the company said.

 

Financial details were not discussed.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.